- Supported exchanges /
- F /
- 4ZU0.F
BIORA THERAPEUT.NEW -001 (4ZU0 F) stock market data APIs
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
BIORA THERAPEUT.NEW -001 Financial Data Overview
| 5.1 | |
| 5.1 | |
| - | |
| 5.1 | |
| 5.1 | |
| 0.0392-5.1 | |
| 1 876 K | |
| 3 678 K | |
| 860 K | |
| 1.233 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
BIORA THERAPEUT.NEW -001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 860 K
- EBITDA -67 510 000
- Earnings Per Share -45.4
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get BIORA THERAPEUT.NEW -001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get BIORA THERAPEUT.NEW -001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
